T

(redirected from tau)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

T

Fifth letter of a Nasdaq stock symbol indicating that the stock has warrants or rights.

T

A symbol appearing next to a stock listed on NASDAQ indicating that the stock is not common issue, but has a warrant attached to it. All NASDAQ listings use a four letter abbreviation; if a T follows the abbreviation, this indicates that the security being traded has a warrant attached.

t

1. Used in the dividend column of stock transaction tables in newspapers to indicate the market value as of the distribution date of stock dividends paid during the preceding 12 months. Stocks with this listing paid no cash dividends: Jetron .71t.
2. Used in bond transaction tables in newspapers to indicate a floating-rate bond or note: Amoco 8.05s89t.
References in periodicals archive ?
Tau reduction looks promising in this regard, although a lot more work needs to be done before such approaches can be explored in humans," said Mucke.
8220;Vung Tau preserves the feel of a harmonious community of religions, mountains, beaches, architecture old and news.
They had previously shown a reduction of beta amyloid in people treated with AN1792 and now looked to see if it had any effect on tau.
In a test tube, Pin-1 can make phosphorylated tau proteins resume their normal function.
In each of four cases, or events, one track caroms off at a new angle after about a millimeter--the giveaway that a tau lepton from the tau neutrino-nucleus impact decayed into another charged particle plus neutral companions.
If you treat patients who have a low level of Tau protein expression with pre-operative chemotherapy in neo-adjuvant studies, they are very likely to have a good response to the chemotherapy.
If brain cells can secrete and take in clumps of tau, the scientists believe, these clumps may cause previously normal tau in the receiving cell to become corrupted, fostering the spread of a form of tau involved in disease.
These results indicate that a particular subset of tau oligomer structures may be pathological factors in AD and adds to accumulating evidence that extracellular tau oligomers may be part of a key mechanism in AD pathogenesis.
Tau occurs predominantly in neuronal axons, where it binds to microtubules and regulates their length and "treadmilling" dynamics.
LaFerla suspects that amyloid collaborates with tau to kill neurons and trigger the confusion and memory loss that mark the disease.
The emergence of the two development programs in Tau and Complement follow from iPierian's decision to focus its drug discovery programs exclusively on neurodegenerative diseases, an area where access to patient brain tissue for study remains elusive.
Funds to Advance Research Across Key Tau Programs in Alzheimer's disease